이상반응 보고
| VAERS ID | 2155919 |
|---|---|
| 성별 | 남성 |
| 나이 | 75세 |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | ACB5038 |
| 예방접종 횟수 | 3 |
| 접종일 | 2022-02-10 |
| 발병일 | 2022-02-16 |
| 상태 | 사망 |
증상
- 가슴 불편함(Chest discomfort)
- 호흡곤란(Dyspnoea)
- 가슴 통증(Chest pain)
- 죽음(Death)
- 순환기 허탈(Circulatory collapse)
이환 중 질병
Aphasia; Apoplexy; Arterial hypertension; Carotid artery stenosis; Diabetes mellitus insulin-dependent; Hemiparesis
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Unknown cause of death; Circulatory failure; Thoracic pain/acute thoracic complaints; Chest tightness/feeling of tightness; shortness of breath; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from the Regulatory Authority .
Regulatory number: DE-PEI-CADR2022276850.
Other Case identifier(s): DE-CADRPEI-2022276850, DE-PEI-202200078628.
A 75 year-old male patient received bnt162b2 (COMIRNATY), administration date 10Feb2022 (Lot number: ACB5038) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation.
Relevant medical history included: "Carotid artery stenosis" (ongoing); "Arterial hypertension" (ongoing); "Hemiparesis" (ongoing); "Aphasia" (ongoing); "Apoplexy" (ongoing); "Diabetes mellitus insulin-dependent" (ongoing).
The patient's concomitant medications were not reported.
Vaccination history included: Comirnaty (DOSE 1, STRENGTH: 0.
3 mL, batch/lot# unknown), administration date: 03Jun2021, for Prophylactic vaccination; Comirnaty (DOSE 2, STRENGTH: 0.
3 mL, batch/lot# unknown), administration date: 29Jun2021, for Prophylactic vaccination.
The following information was reported: DEATH (death, medically significant) with onset 16Feb2022, outcome "fatal", described as "Unknown cause of death"; CIRCULATORY COLLAPSE (medically significant) with onset 16Feb2022, outcome "not recovered", described as "Circulatory failure"; CHEST PAIN (medically significant) with onset 16Feb2022, outcome "not recovered", described as "Thoracic pain/acute thoracic complaints"; CHEST DISCOMFORT (medically significant) with onset 16Feb2022, outcome "not recovered", described as "Chest tightness/feeling of tightness"; DYSPNOEA (medically significant) with onset 16Feb2022, outcome "not recovered", described as "shortness of breath".
Therapeutic measures were taken as a result of circulatory collapse, chest pain, chest discomfort, dyspnoea.
The patient date of death was 16Feb2022.
The reported cause of death was "Unknown cause of death".
It was not reported if an autopsy was performed.
Clinical course: on the night of 16Feb2022 the patient was with a previously relative well-being an acute thoracic complaints with shortness of breath and a feeling of tightness, then deteriorated and required resuscitation due to electromechanical dissociation.
Circulation could not be established under Cardiopulmonary Resuscitation, died after one hour of resuscitation.
Relatedness of drug to reaction(s)/events: Comirnaty with events Unknown cause of death, Chest tightness, Dyspnoea, Thoracic pain and Circulatory failure via Regulatory Authority.
Unclassifiable.
No follow-up attempts are possible.
No further information is expected.
; Reported Cause(s) of Death: Unknown cause of death